Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.65 - $1.1 $92,968 - $157,330
-143,028 Reduced 55.36%
115,349 $95,000
Q4 2022

Feb 14, 2023

SELL
$0.48 - $0.88 $28,253 - $51,798
-58,862 Reduced 18.55%
258,377 $169,000
Q3 2022

Nov 14, 2022

SELL
$0.79 - $22.0 $441,573 - $12.3 Million
-558,954 Reduced 63.79%
317,239 $273,000
Q2 2022

Aug 15, 2022

BUY
$0.8 - $1.5 $596,324 - $1.12 Million
745,405 Added 569.93%
876,193 $736,000
Q1 2022

May 16, 2022

BUY
$1.24 - $2.75 $162,177 - $359,667
130,788 New
130,788 $178,000
Q3 2021

Nov 15, 2021

SELL
$2.82 - $3.7 $97,631 - $128,097
-34,621 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.5 - $5.48 $51,261 - $80,260
14,646 Added 73.32%
34,621 $124,000
Q1 2021

May 17, 2021

SELL
$3.16 - $4.89 $1.95 Million - $3.01 Million
-615,647 Reduced 96.86%
19,975 $71,000
Q4 2020

Feb 16, 2021

SELL
$2.2 - $4.45 $97,880 - $197,984
-44,491 Reduced 6.54%
635,622 $2.02 Million
Q3 2020

Nov 16, 2020

BUY
$2.62 - $4.78 $644,540 - $1.18 Million
246,008 Added 56.67%
680,113 $2.75 Million
Q2 2020

Aug 14, 2020

SELL
$1.83 - $3.16 $10,732 - $18,533
-5,865 Reduced 1.33%
434,105 $1.16 Million
Q1 2020

May 14, 2020

BUY
$1.14 - $2.96 $200,163 - $519,722
175,582 Added 66.41%
439,970 $832,000
Q4 2019

Feb 14, 2020

SELL
$1.25 - $2.57 $182,121 - $374,441
-145,697 Reduced 35.53%
264,388 $679,000
Q3 2019

Nov 14, 2019

SELL
$1.26 - $1.96 $397,301 - $618,025
-315,319 Reduced 43.47%
410,085 $578,000
Q2 2019

Aug 14, 2019

BUY
$1.43 - $1.94 $1.04 Million - $1.41 Million
725,404 New
725,404 $1.09 Million
Q2 2018

Aug 14, 2018

SELL
$2.92 - $5.1 $134,947 - $235,696
-46,215 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$3.42 - $5.35 $17,688 - $27,670
-5,172 Reduced 10.06%
46,215 $210,000
Q4 2017

Feb 14, 2018

SELL
$3.26 - $4.84 $306,453 - $454,979
-94,004 Reduced 64.66%
51,387 $205,000
Q3 2017

Nov 14, 2017

BUY
$3.83 - $4.89 $556,847 - $710,961
145,391
145,391 $643,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $194M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.